Related references
Note: Only part of the references are listed.EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease
A. Berardelli et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes
Nin Bajaj et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)
Nigrostriatal Dopamine Terminal Imaging with Dopamine Transporter SPECT: An Update
Klaus Tatsch et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Efficacy Considerations for US Food and Drug Administration Approval of Diagnostic Radiopharmaceuticals
Alexander Gorovets et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
Bradley T. Hyman et al.
ALZHEIMERS & DEMENTIA (2012)
Interobserver variability, and visual and quantitative parameters of 123I-FP-CIT SPECT (DaTSCAN) studies
Nikolaos Papathanasiou et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementias
Sean J. Colloby et al.
BRAIN (2012)
EFNS task force: the use of neuroimaging in the diagnosis of dementia
M. Filippi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia
S. Sorbi et al.
EUROPEAN JOURNAL OF NEUROLOGY (2012)
Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled study
Andreas R. Kupsch et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT
Shirlony Morgan et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)
SNM Practice Guideline for Dopamine Transporter Imaging with 123I-Ioflupane SPECT 1.0
David S. W. Djang et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System Atrophy
Minyoung Oh et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
123I-FP-CIT SPECT imaging of the dopaminergic state Visual assessment of dopaminergic degeneration patterns reflects quantitative 2D operator-dependent and 3D operator-independent techniques
D. Kahraman et al.
NUKLEARMEDIZIN-NUCLEAR MEDICINE (2012)
Diagnostic accuracy of 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: A meta-analysis of published studies
Nikolaos D. Papathanasiou et al.
PARKINSONISM & RELATED DISORDERS (2012)
Diagnostic Accuracy of Combined FP-CIT, IBZM, and MIBG Scintigraphy in the Differential Diagnosis of Degenerative Parkinsonism: A Multidimensional Statistical Approach
Martin Suedmeyer et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study
Alex Iranzo et al.
LANCET NEUROLOGY (2011)
The Parkinson Progression Marker Initiative (PPMI)
Kenneth Marek et al.
PROGRESS IN NEUROBIOLOGY (2011)
Interobserver agreement in the visual and semi-quantitative analysis of the 123I-FP-CIT SPECT images in the diagnosis of Parkinsonian syndrome
M. Suarez-Pinera et al.
REVISTA ESPANOLA DE MEDICINA NUCLEAR (2011)
Cortical and Subcortical Patterns of I-123 Iodobenzamide SPECT in Striatal D2 Receptor Parkinsonisms
Paloma Pifarre et al.
CLINICAL NUCLEAR MEDICINE (2010)
Differentiating Vascular Parkinsonism from Idiopathic Parkinson's Disease: A Systematic Review
Seema Kalra et al.
MOVEMENT DISORDERS (2010)
Diagnostic accuracy of I-123-FP-CIT SPECT in possible dementia with Lewy bodies
John T. O'Brien et al.
BRITISH JOURNAL OF PSYCHIATRY (2009)
Direct comparison of FP-CIT SPECT and F-DOPA PET in patients with Parkinson's disease and healthy controls
S. A. Eshuis et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
Impact of dopamine transporter single photon emission computed tomography imaging using I-123 ioflupane on diagnoses of patients with parkinsonian syndromes
C. Bairactaris et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2009)
Parkinson's Disease is Overdiagnosed Clinically at Baseline in Diagnostically Uncertain Cases: A 3-Year European Multicenter Study with Repeat [123I]FP-CIT SPECT
Vicky L. Marshall et al.
MOVEMENT DISORDERS (2009)
Diagnostic value of I-123-ioflupane and I-123-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes
Annemarie M. M. Vlaar et al.
EUROPEAN NEUROLOGY (2008)
A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies
Sean J. Colloby et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
Brain parenchyma Sonography and 123I-FP-CIT SPECT in Parkinson's disease and essential tremor
Florian Doepp et al.
MOVEMENT DISORDERS (2008)
Accuracy of DaTSCAN (123I-Ioflupane) SPECT in diagnosis of patients with clinically uncertain parkinsonism:: 2-year follow-up of an open-label study
Eduardo Tolosa et al.
MOVEMENT DISORDERS (2007)
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy
Zuzana Walker et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Meta-analysis of the literature on diagnostic accuracy of SPECT in Parkinsonian syndromes
Annemarie M. M. Vlaar et al.
BMC NEUROLOGY (2007)
Diagnostic accuracy of FP-CIT SPECT in patients with parkinsonism
S. J. Ortega Lozano et al.
REVISTA ESPANOLA DE MEDICINA NUCLEAR (2007)
Does combined imaging of the pre- and postsynaptic dopaminergic system increase the diagnostic accuracy in the differential diagnosis of parkinsonism?
Walter Koch et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Sensitivity and specificity of dopamine transporter imaging with (123)I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study
Ian McKeith et al.
LANCET NEUROLOGY (2007)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the Consortium on DLB International Workshop
Ian G. McKeith
JOURNAL OF ALZHEIMERS DISEASE (2006)
Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT
K Stiasny-Kolster et al.
BRAIN (2005)
Impact of dopamine transporter SPECT using 123I-ioflupane on diagnosis and management of patients with clinically uncertain Parkinsonian syndromes
AM Catafau et al.
MOVEMENT DISORDERS (2004)
Dopamine transporter SPECT using fast kinetic ligands:: 123I-FP-β-CIT versus 99mTc-TRODAT-1
K Van Laere et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies
JT O'Brien et al.
ARCHIVES OF NEUROLOGY (2004)
123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy
A Antonini et al.
NEUROLOGICAL SCIENCES (2003)
SIC Task Force appraisal of clinical diagnostic criteria for Parkinsonian disorders
I Litvan et al.
MOVEMENT DISORDERS (2003)
How valid is the clinical diagnosis of Parkinson's disease in the community?
A Schrag et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2002)
Novel three-stage ascertainment method - Prevalence of PD and parkinsonism in South Tyrol, Italy
B Kis et al.
NEUROLOGY (2002)
Research evaluation and prospective diagnosis of dementia with Lewy bodies
OL Lopez et al.
ARCHIVES OF NEUROLOGY (2002)
Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease
AJ Hughes et al.
NEUROLOGY (2001)
Prospective validation of Consensus criteria for the diagnosis of dementia with Lewy bodies
IG McKeith et al.
NEUROLOGY (2000)
Share Paper
